JBC Avanti Polar Lipids

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kaasch, A. J.
Right arrow Articles by Joiner, K. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kaasch, A. J.
Right arrow Articles by Joiner, K. A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 275, Issue 2, 1112-1118, January 14, 2000


Targeting and Subcellular Localization of Toxoplasma gondii Catalase
IDENTIFICATION OF PEROXISOMES IN AN APICOMPLEXAN PARASITE*

Achim J. Kaasch and Keith A. JoinerDagger

From the Section of Infectious Diseases, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut 06520-8022

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

We sought to identify and characterize peroxisomes in the apicomplexan parasite Toxoplasma gondii. To initiate this process, we first cloned and sequenced the gene for T. gondii catalase (EC 1.11.1.6), a marker enzyme for peroxisomes in eukaryotic cells. The gene predicts a protein of 57.2 kDa and 502 amino acids and has a strong homology to other eukaryotic catalases. A polyclonal antiserum raised against a glutathione S-transferase fusion protein recognized a single band with a molecular mass of 63 kDa by immunoblot. By immunofluorescence T. gondii catalase is present primarily in a punctate staining pattern anterior to the parasite nucleus. This compartment is distinguishable from other parasite organelles, namely micronemes, rhoptries, dense granules, and the apicoplast. Cytochemical visualization of catalase using diaminobenzidine precipitation gives a vesicular staining pattern anterior to the nucleus at the light level and round, vesicular structures with an estimated diameter of 100-300 nm by electron microscopy. T. gondii catalase has a putative C-terminal peroxisomal targeting signal in the last 3 amino acids (-AKM). Expression of T. gondii catalase in mammalian cells results in peroxisomal localization, whereas a construct lacking the targeting signal remains in the cytosol. Furthermore, addition of -AKM to the C terminus of chloramphenicol acetyltransferase is sufficient to target this protein to peroxisomes. These results provide the first evidence for peroxisomes in Apicomplexan parasites.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Apicomplexan parasites such as Toxoplasma, Cryptosporidium, Plasmodium, and Eimeria are prevalent worldwide and cause disease in humans and livestock. Toxoplasma gondii is responsible for opportunistic infections in immunosuppressed individuals, in particular AIDS and transplant patients, and congenital infections in newborns.

T. gondii is an obligate intracellular parasite that can survive and replicate inside many cell types, including activated macrophages. This suggests that the parasite has mechanisms to evade the macrophage respiratory burst (1). Previous studies have shown that the parasite is remarkably resistant to hydrogen peroxide and can quench released oxygen radicals (2). These phenomena are attributed to the high level expression of catalase and superoxide dismutase (3) and their ability to decompose H2O2. Despite their importance, no further effort has been made to characterize these enzymes in detail.

Catalase (EC 1.11.1.6) is a marker enzyme of peroxisomes or microbodies. These subcellular organelles compartmentalize more than 50 different enzymes that intersect with a large variety of anabolic and metabolic pathways. In mammalian cells, these pathways include peroxide metabolism, beta -oxidation of fatty acids, and ether phospholipid synthesis. Most peroxisomal enzymes are synthesized on free ribosomes and then post-translationally imported into peroxisomes through an evolutionarily conserved machinery (4). Several types of peroxisomal targeting signals (PTS)1 have been identified. PTS1, the C-terminal peroxisomal targeting signal, resides in the last 3 amino acids that share the following consensus motif: (S/T/A/G/C/N)-(R/K/H)-(L/I/V/M/A/F/Y) (PROSITE, Swiss Institute of Bioinformatics). However, not all combinations have been tested, and residues upstream of this signal are known to influence the recognition of this motif (5).

A well characterized example of microbodies in protozoan parasites are the glycosomes of the Kinetoplastidae, e.g. Leishmania and Trypanosoma (6). These organelles, most prominent in the bloodstream form of these parasites, notably compartmentalize glycolytic enzymes but surprisingly do not contain catalase. Protein import into glycosomes is thought to be mediated by a similar mechanism as reported for mammalian peroxisomal import. In the phylum Apicomplexa, however, peroxisomes or related particles have never been defined.

In this study we report the cloning of T. gondii catalase, its subcellular localization in peroxisomes, and its targeting, mediated through a PTS1 signal. This is the first evidence for the existence of a peroxisomal compartment in any Apicomplexan parasite.

    MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Cell Culture and Growth of T. gondii-- The RH strain of T. gondii was maintained by growth in monolayers of either African Green monkey (Vero) cells or human foreskin fibroblasts as described previously (7). Chinese hamster ovary (CHO) cells were cultured in alpha -minimum Eagle's medium supplemented with 3.5% fetal bovine serum, 2 mM L-glutamine, and penicillin/streptomycin at 37 °C in 5% CO2 atmosphere.

Cloning and Sequencing of T. gondii Catalase-- A catalase proximal heme-ligand signature (PROSITE, Swiss Institute of Bioinformatics) was found in two sequences of the EST data base of the Toxoplasma EST project (8). Both lambda phage clones (GenBankTM accession numbers W9973 and W6349) were obtained from Genome Systems (St. Louis, MO), in vivo excised with VCSM13 (Stratagene, Menasha, WI) as helper phage and sequenced. The upstream sequence was obtained by 5'-rapid amplification of cDNA ends (anchor primers: R1, R2, and R3 see Table I) and by RT-PCR with a degenerate primer (Fdeg) against a highly conserved motif in eukaryotic catalases and two specific reverse primers (R4 and R5). A second 5'- rapid amplification of cDNA ends (anchor primers: R6, R7, and R9) revealed the missing upstream region. The sequence was confirmed by RT-PCR with specific primers against the 5'- and 3'-untranslated regions (F4 and R0), and four independent clones were sequenced. For RT-PCR and rapid amplification of cDNA ends applications, RNA was isolated using TRIzol reagent and transcribed with Superscript II reverse transcriptase according to the manufacturer's instructions (Life Technologies, Inc.). DNA sequences were obtained by dideoxy sequencing of both strands at the W. M. Keck Sequencing Center, Yale University School of Medicine. The strategy for determining the nucleotide sequence of T. gondii catalase is shown in Fig. 1.

                              
View this table:
[in this window]
[in a new window]
 
Table I
Primer sequences
Primer sequences used in this work are shown. Bases that code for restriction sites are in bold. (All oligonucleotides were purchased from HHMI Biopolymer Laboratory and W. M. Keck Foundation Biotechnology Resource Laboratory at Yale University.) I, inosine; n, A,C,G,T; r, A,G; m, A,C; y, C,T.


View larger version (5K):
[in this window]
[in a new window]
 
Fig. 1.   Sequencing strategy. Catalase of T. gondii was cloned by a combination of techniques. The bars show the method used to determine the indicated part of the sequence. The 5'- and 3'-untranslated regions are shown by open boxes; the coding sequence is shown by the black box. The arrows denote the positions of the primers.

Production of Antiserum to a GST-Catalase Fusion-- The nucleotide sequence that codes for the C-terminal part of T. gondii catalase (aa 335-502) was amplified by PCR (primers ExF and ExR) and cloned in frame into the BamHI and XmaI site of the pGEX-4T-1 expression vector (Amersham Pharmacia Biotech). The resulting glutathione S-transferase (GST) fusion protein was expressed in the Escherichia coli strain DH5alpha . Synthesis of the GST fusion protein was induced with 0.5 mM isopropyl-1-thio-beta -D-galactopyranoside for 4-6 h at 37 °C. The protein was solubilized with N-laurylsarcosine (9) and affinity purified on glutathione-Sepharose beads (Sigma). Rabbit preimmune sera were screened by immunoblot for low background recognition of T. gondii antigens, and a suitable animal was chosen. Immunization and antiserum production were carried out by Cocalico Biologicals (Reamstown, PA).

Immunoblot with Anti-T. gondii Catalase-- About 5 × 106 parasites (or an equivalent amount of host cell material) were collected by centrifugation, separated on a 10% SDS-polyacrylamide gel, and transferred onto nitrocellulose membrane. The membranes were probed with a 1:500 dilution of anti-T. gondii catalase antiserum, followed by a 1:2000 dilution of horseradish peroxidase-conjugated anti-rabbit IgG antibody (Calbiochem). The signal was visualized with the ECL kit (Amersham Pharmacia Biotech). As a control, incubation with preimmune serum at a 1:100 dilution was performed.

Antibody Purification-- The rabbit antiserum to T. gondii catalase was purified by adsorption to the 47-kDa band of the purified recombinant antigen on an immunoblot, as described previously (10). Alternatively, the antiserum was affinity purified against the GST fusion protein coupled to cyanogen bromide-activated agarose (Sigma). The antibody was bound to the column in phosphate-buffered saline (PBS), pH 7.4, eluted with 0.2 M glycine, pH 2.8, and the pH of the eluate was immediately readjusted by adding 1 M Tris base.

Immunofluorescence Assay-- The immunofluorescence assay (IFA) for intracellular parasites was performed as described previously (11), using 3% paraformaldehyde as fixative. Extracellular parasites were fixed in ice-cold acetone for 15 min and then processed similarly. Controls included incubation with preimmune serum, secondary antibody alone, and competition experiments with the purified GST fusion protein. The following dilutions of antibodies were used: fluorescein isothiocyanate (FITC)-linked goat anti-rabbit IgG (Calbiochem) at 1:500; rhodamine-linked goat anti-mouse (Roche Molecular Biochemicals) at 1:500; affinity purified rabbit anti-catalase at 1:5; murine monoclonal anti-ROP2,3,4 (T3 4A7) at 1:250; murine monoclonal anti-GRA3 (T6 2H11) at 1:250; and murine monoclonal anti-MIC2 (D2R3) at 1:250. All monoclonal antibodies were generously provided by J. F. Dubremetz, Lille, France. The apicoplast was stained with 4',6-diamidino-2-phenylindole (12).

For IFA on CHO cells, the same protocol as for intracellular parasites was applied. Antibody concentrations used were as follows: rabbit anti-chloramphenicol acetyltransferase antibody (5 Prime right-arrow 3 Prime Inc., Boulder, CO) at 1:500; rabbit anti-catalase antiserum at 1:250,and rabbit anti-SKL antibody (Zymed Laboratories Inc., South San Francisco, CA) at 1:500.

Cytochemical EM-- Diaminobenzidine (DAB) staining for catalase was performed according to established procedures (13). In brief, parasites were fixed for 15 min with 1.5% glutaraldehyde in 0.1 M PIPES buffer, pH 7.4, washed once in PBS, pH 7.4, and one time in Teorell-Stenhagen buffer (T/S: 50 mM boric acid, 10 mM phosphoric acid, 2.5 mM citric acid brought to pH 10.5 by NaOH). Following a 1-h preincubation in DAB (2 mM in T/S) at room temperature, H2O2 was added to a final concentration of 0.15% for 1-3 h. After washing in T/S and 100 mM sodium cacodylate buffer, pH 7.4, the sample was fixed overnight with 2.5% glutaraldehyde in 100 mM sodium cacodylate at 4 °C and embedded in Epon (Electron Microscopy Sciences, Fort Washington, PA). Ultrathin 60-80 nm sections were mounted on Formvar-coated nickel grids (Electron Microscopy Sciences). The sections were not counterstained in order to facilitate recognition of the DAB precipitate. As a control, DAB incubations were done in the presence of 20 mM 3-amino-1,2,4-triazole or alternatively H2O2 was omitted. For light microscopy, the above procedure was performed on coverslips that were mounted and examined after the H2O2 incubation.

Import Assays in Mammalian Cells-- Chloramphenicol acetyltransferase (CAT) and T. gondii catalase expression in CHO cells was driven by the cytomegalovirus promoter. CAT-AKM was ligated into the HindIII and KpnI site (CATFHind, CATAKMKpn) of pcDNA3.1/Zeo(+) (Invitrogen, Carlsbad, CA). For a cytosolic control, CAT in the pcDNA3.1/Zeo/CAT vector (Invitrogen) was used. T. gondii catalase was cloned into NheI and BamHI sites of pcDNA3.1/Zeo(+) using NheCat, AKMBgl (full-length catalase), and CYPBgl (C-terminal truncation) as primers. CHO cells were transfected using SuperFect (Qiagen, Valencia, CA), following the manufacturer's instructions. The cells were plated on coverslips 24-48 h after transfection, and IFA was performed 24 h later.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Analysis of the Catalase Sequence-- The deduced amino acid sequence of T. gondii catalase encodes a protein of 502 residues with a predicted molecular mass of 57.2 kDa (Fig. 2). Evaluation of the protein sequence by BLASTP (14) shows a high degree of identity with other catalases (e.g. 53% identity with human catalase), whereas comparison of the T. gondii catalase nucleotide sequence with eukaryotic catalases reveals only minimal similarity. This suggests, along with additional data provided below (Fig. 4), that the deduced catalase sequence is derived from T. gondii and not from host cell contamination.


View larger version (48K):
[in this window]
[in a new window]
 
Fig. 2.   Nucleotide sequence and predicted translation of T. gondii catalase. The T. gondii catalase sequence is available in GenBankTM (accession number AF136344). The underlined bases denote the position of the respective oligonucleotides in Table I.

Further analysis confirms that this protein is indeed a catalase. Foremost, both catalase consensus patterns (15) are present: the active site signature at position 53-69 (consensus, (IF)X(RH)X4(EQ)RX2HX2(GAS)-(GASTF)-(GAST)) and at position 343-351 the proximal heme ligand signature (consensus, R-(LIVMFSTAN)-F-(GASTNP)YXD(AST)-(QEH)) (Fig. 3).


View larger version (50K):
[in this window]
[in a new window]
 
Fig. 3.   Sequence alignment for catalases of various species. Catalases from the following species are aligned with T. gondii catalase (NCBI accession number AF136344): H. sapiens (NCBI accession number 179950), C. elegans (NCBI accession number 1078837), S. cerevisiae (NCBI accession number 115709). Dots in the sequence indicate that the residues are identical to the aligned T. gondii residues, whereas a dash denotes a gap. Symbols below the alignment show residues that have the following possible function: distal heme binding residues are denoted by >, proximal heme binding residues by <; residues that bind the propionate side chains of the heme by . &cjs3419; indicates residues neighboring the active center; open circle  indicates NADPH binding participants; dagger  denotes residues proposed to be involved in the catalytic mechanism; cap  shows residues in the environment of NADPH; black-triangle indicates residues that build the substrate channel; Dagger  denotes residues that are critical for tetramerization. The putative PTS1 signals are printed in bold, whereas the active site signature (aa 53-69) and the proximal heme-binding signature (aa 343-351) are underlined. The alignment was performed by ClustalW1.73.

Residues that comprise the active site are absolutely identical to human catalase (Phe-142, Phe-150, and Phe-53 as distal and His-207 and Arg-343 as proximal heme binding partners; Arg-61, Arg-101, and Arg-354 as binding partners for the propionate groups of the heme). Residues neighboring the active center are also conserved (Tyr-347, Asp-54, His-64, Val-135, and Phe-323), with minor alterations (S346A and L50M) in human catalase (16). Residues that are thought to play a role in the catalytic mechanism are also conserved (His-64, Asn-137, Ser-103, and Tyr-347) (17).

Some catalases, e.g. human or bovine catalase, are NADPH-containing enzymes (16). NADPH is thought to prevent the formation of compound II, an inactive state in the catalytic cycle (18). Sequence conservation suggests that T. gondii catalase may also bind NADPH as a cofactor. Residues possibly involved in NADPH binding (Arg-192, Thr-190, Asn-202, His-294, His-183, Gln-435, Trp-292, His-224, and Val-443) and residues in the environment of the putative NADPH-binding site (Glu-448, Phe-187, Thr-139, Pro-140, Tyr-204, Lys-226, Gln-271, Pro-293, Val-291, Phe-439, and Leu-444) are identical to the human sequence with the exception of Thr-190 and Glu-448 (16).

The substrate H2O2 is thought to diffuse to the active site through an approximately 30-Å long channel (16). Residues that build the walls of the narrow part of this channel are identical to the human sequence (Val-105, Ala-106, Asp-117, Pro-118, Phe-142, Phe-143, Phe-150, Phe-153, Ile-154, Val-185, Leu-188, Gln-157, and Lys-158), suggesting that the range of potential substrates is similar (19).

Most catalases exist as homotetramers. Residues that are known to be involved in subunit interactions in Proteus mirabilis catalase are identical with the corresponding residues in T. gondii catalase (Leu-50, Asp-54, Phe-53, Asp-349, Arg-55, P. mirabilis alignment not shown) (16). Human and bovine catalases, which have a longer C terminus, also stabilize the subunit interactions with these additional amino acids.

T. gondii catalase contains a putative peroxisomal targeting signal (PTS1) at the C terminus. The last three residues of the protein (-AKM) match the consensus motif of C-terminal peroxisomal targeting signals ((S/T/A/G/C/N)-(R/K/H)-(L/I/V/M/A/F/Y)). This motif has been shown to be a PTS1, albeit a weak one, when linked to CAT and expressed in monkey kidney (CV1) cells (20).

Anti-catalase Antiserum Recognizes a 63-kDa Protein-- Antiserum was raised to a fusion protein between GST and residues 335-502 of T. gondii catalase. This region of T. gondii catalase is comparatively divergent to human catalase and was therefore chosen as antigen.

As expected the antiserum recognizes the recombinant GST-catalase fusion protein migrating at 47 kDa (Fig. 4, 3rd lane). This antiserum recognizes a single band on immunoblot, when tested against whole parasites (Fig. 4, 1st lane). This protein migrates at 63 kDa, which is in reasonable agreement with the predicted size (57.2 kDa) of T. gondii catalase. The parasite protein expressed in CHO cells also migrates with the same Mr (data not shown). No signal is observed with uninfected host cells (Fig. 4, 2nd lane) or with preimmune serum (data not shown), indicating that the band constitutes a T. gondii protein.


View larger version (9K):
[in this window]
[in a new window]
 
Fig. 4.   Immunoblot with antiserum against a GST-catalase fusion. Whole parasite lysates (from organisms grown in Vero cells) were probed by immunoblot with the antiserum to T. gondii catalase. A 63-kDa protein was detected in the parasite lysate (1st lane). No signal was observed in the negative control with lysates of uninfected Vero cells (2nd lane). The purified GST-catalase fusion protein serves as a positive control, migrating at the predicted size of 47 kDa (3rd lane).

Catalase Localizes to a New, Distinct Compartment Anterior to the Nucleus by IFA-- Anti-catalase antiserum recognizes a punctate, beaded structure anterior to the nucleus by immunofluorescence (Fig. 5). Additionally there is a weak but specific, diffuse signal throughout the parasite, which might correspond to a cytosolic pool of the protein. Colocalization experiments show that the catalase localization is distinct from other parasite organelles, namely micronemes, rhoptries, dense granules, and the apicoplast (Fig. 6).


View larger version (104K):
[in this window]
[in a new window]
 
Fig. 5.   Immunofluorescence assay with anti-catalase antibody. Affinity purified antibody to T. gondii catalase was used for IFA with intracellular and extracellular parasites. Intracellularly replicating parasites (a) form a rosette inside a vacuole with the anterior end of the parasite pointing outwards. b, such a vacuole with eight parasites is depicted schematically on top of the phase image. In one parasite the nucleus (N) and catalase-containing vesicles are indicated. In extracellular parasites (c) the catalase-containing vesicles seem to be more condensed, possibly a result of the different fixation. d, shows the corresponding phase image to c. Scale bar, 2 µm.


View larger version (57K):
[in this window]
[in a new window]
 
Fig. 6.   IFA colocalization of catalase with various parasite markers. Catalase (green channel) does not colocalize with various parasite organelles by IFA. Micronemes (a), rhoptries (c), and dense granules (e) (all in the red channel) are labeled with monoclonal mouse antibodies to organellar proteins. The corresponding phase images are shown in b and d. The localization of the apicoplast DNA (f) is visualized by 4'6-diamidino-2-phenylindole staining (red channel) and denoted by arrows; the arrowheads point to the parasite nuclei. Scale bar, 2 µm.

Catalase Localization by Histocytochemistry-- Catalase was localized in T. gondii by histocytochemistry. Catalase can be visualized by precipitation of diaminobenzidine (DAB) under conditions of mild fixation, high substrate (hydrogen peroxide) concentrations, and high pH buffer. The precipitate can be seen in light microscopy as dark spots inside the parasite (Fig. 7c). Treatment with 20 mM 3-amino-1,2,4-triazole, a catalase inhibitor, abolishes the staining (data not shown).


View larger version (161K):
[in this window]
[in a new window]
 
Fig. 7.   Catalase cytochemistry by DAB precipitation. Electron micrographs (a and b) of intracellular parasites. M, mitochondrion; N, nucleus; and P, peroxisome (scale bar, 0.5 µm). The inset in a shows a higher magnification of a labeled peroxisome (scale bar, 50 nm). In light microscopy the precipitate can be seen as dark spots in the phase image (c, arrows). d, is the corresponding Nomarski image for c (scale bar, 5 µm).

By electron microscopy a specific reaction product appears in a juxtanuclear position as a round structure of about 100-300 nm (Fig. 7, a and b). It frequently possesses a core with a crystalloid shape. Reaction product in the mitochondrion is not specific for catalase, since it is still prevalent under inhibitor treatment or when the substrate hydrogen peroxide is omitted (data not shown).

Putative PTS1 Is Necessary and Sufficient for Targeting to Mammalian Peroxisomes-- The functionality of the C-terminal -AKM motif as a peroxisomal targeting signal was tested by expressing T. gondii catalase in CHO cells, which provide a well defined peroxisomal compartment. Transiently expressed full-length T. gondii catalase localizes to particulate structures that show the same staining pattern as peroxisomes (Fig. 8, c and e). The truncated version of catalase, without the last three amino acids, yields a diffuse staining pattern (Fig. 8d), which is consistent with a predicted cytosolic localization.


View larger version (69K):
[in this window]
[in a new window]
 
Fig. 8.   Import of T. gondii catalase and CAT in CHO cells. Peroxisomal localization of CAT-AKM (a) and diffuse, cytosolic staining pattern (b) of CAT lacking the PTS1 signal. Full-length T. gondii catalase, visualized with anti-catalase antiserum, gives a particulate staining pattern (c). Deletion of the last three amino acids (-AKM) abolishes peroxisomal localization and gives a cytosolic distribution (d). Typical peroxisomal staining with a polyclonal rabbit Anti-SKL antibody is shown in e. Scale bar, 5 µm.

To address the question whether the -AKM motif is sufficient to target proteins to peroxisomes, CAT was used as a marker protein. CAT resides in the cytosol and therefore has a diffuse staining pattern (Fig. 8b). Addition of -AKM to the C terminus (CAT-AKM) relocates the protein to particulate structures (Fig. 8a), suggesting a peroxisomal localization. To confirm targeting of CAT to peroxisomes we expressed CAT-SKL, which is known to reside in peroxisomes (data not shown).

    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Catalase is the characteristic marker enzyme of peroxisomes and is highly conserved across species. The deduced amino acid sequence of T. gondii catalase has typical features of eukaryotic catalases, e.g. residues that are known to be involved in heme binding, NADPH binding, tetramerization, and protein import are strongly conserved. This suggests a similar catalytic mechanism and localization in peroxisomes.

We addressed the latter by analyzing catalase distribution by the electron and light microscope. We identified a distinctive, vesicular compartment anterior to the nucleus that does not overlap with known organelles of the parasite. Since peroxisomal proteins reach their subcellular destination through a specific import mechanism that is mediated by evolutionarily conserved signals, we investigated the functionality of the PTS1-type import signal (-AKM) of T. gondii catalase. This PTS1 motif is necessary and sufficient to target T. gondii catalase and chloramphenicol acetyltransferase to mammalian peroxisomes. Although we have not identified a peroxisomal membrane, due to the difficulties in detection of DAB precipitate in counterstained sections, our data remain consistent with the presence of peroxisomes in T. gondii.

The enzymatic activity of catalase, the decomposition of H2O2, and therefore the protection from endogenously produced oxygen radicals are well established. One can also speculate about protection from exogenous H2O2, a mechanism that could potentially facilitate parasite survival during infection. However, in this case, a compartmentalization of catalase seems to be unfavorable, since H2O2 would have to diffuse through the parasite cytosol toward the enzyme. On the other hand, the observed pool of catalase in the parasite cytosol could be sufficient to clear exogenous hydrogen peroxide, whereas the peroxisomal pool might be needed to scavenge the H2O2 production of peroxisomal enzymes.

The biochemical role of peroxisomes in T. gondii has yet to be elucidated. Of particular interest will be to determine the contribution of peroxisomal enzymes in lipid synthesis or metabolism. The parasite seems to be deficient in its ability to synthesize cholesterol and selected phospholipids de novo2 and presumably acquires these components from the host cell. On the other hand, enzymes involved in fatty acid biosynthesis are imported into the T. gondii apicoplast, a chloroplast remnant present in many if not all Apicomplexan parasites (21, 22). Given the presence in T. gondii of genes for isocitrate lyase and malate synthase, two members of the glyoxylate cycle found in plant glyoxysomes, a role for T. gondii peroxisomes in fatty acid conversion in succinate and ultimately to glucose is also possible.3 Determining the relative contribution of these three pathways to lipid homeostasis within T. gondii will require a detailed understanding of the biochemical composition of the T. gondii peroxisomes and may ultimately provide insights into novel therapeutic approaches.

    ACKNOWLEDGEMENTS

We thank P. Lazarow and E. Purdue for helpful discussion and reagents; E. Ullu, A. Sinai, and I. Coppens for careful reading of the manuscript; and members of the Joiner laboratory for their support.

    FOOTNOTES

* This work was supported by National Institutes of Health Grant A130060 and a Burroughs Wellcome Scholar award in Molecular Parasitology (to K. A. J.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) AF136344 and AF136344.

The amino acid sequence of this protein can be accessed through NCBI Protein Database under NCBI accession numbers 179950, 1078837, and 115709.

Dagger To whom correspondence should be addressed: Infectious Diseases Section, Dept. of Internal Medicine, 808 LCI, 333 Cedar St., New Haven, CT 06520-8022. Tel.: 203-785-4140; Fax: 203-785-3864; E-mail: keith.joiner@yale.edu.

2 I. Coppens, A. Sinai, D. Voelker, and K. A. Joiner, unpublished observations.

3 E. Mui, B. Samuel, D. Mack, C. Roberts, C. Pope, F. Roberts, D. Trelease, W. Milhous, D. Kyle, S. Tzipori, and R. McLeod, Fifth Toxoplasma Conference, Marshall, CA, May 1-6, 1999.

    ABBREVIATIONS

The abbreviations used are: PTS, peroxisomal targeting signal; PBS, phosphate buffered saline; DAB, diaminobenzidine; GST, glutathione S-transferase, T/S, Teorell-Stenhagen buffer; CAT, chloramphenicol acetyltransferase; IFA, immunofluorescence assay; RT-PCR, reverse transcriptase-polymerase chain reaction; CHO, Chinese hamster ovary; PIPES, 1,4-piperazinediethanesulfonic acid; aa, amino acids.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

1. Murray, H. W., and Cohn, Z. A. (1979) J. Exp. Med. 150, 938-949[Abstract/Free Full Text]
2. Chang, H. R., and Pechere, J. C. (1989) Microb. Pathog. 7, 37-44[CrossRef][Medline] [Order article via Infotrieve]
3. Sibley, L. D., Lawson, R., and Weidner, E. (1986) Mol. Biochem. Parasitol. 19, 83-87[CrossRef][Medline] [Order article via Infotrieve]
4. Gould, S. J., Keller, G. A., Hosken, N., Wilkinson, J., and Subramani, S. (1989) J. Cell Biol. 108, 1657-1664[Abstract/Free Full Text]
5. Purdue, P. E., and Lazarow, P. B. (1996) J. Cell Biol. 134, 849-862[Abstract/Free Full Text]
6. Opperdoes, F. R., Baudhuin, P., Coppens, I., DeRoe, C., Edwards, S. W., Weijers, P. J., and Misset, O. (1984) J. Cell Biol. 98, 1178-1184[Abstract/Free Full Text]
7. Roos, D. S., Donald, R. G., Morissette, N. S., and Moulton, A. L. (1994) Methods Cell Biol. 45, 27-63[Medline] [Order article via Infotrieve]
8. Ajioka, J., Boothroyd, J. C., Brunk, B. P., Hehl, A., Hillier, L., Manger, I. D., Overton, G. C., Marra, M., Roos, D., and Sibley, L. D. (1998) Genome Res. 8, 18-28[Abstract/Free Full Text]
9. Frangioni, J. V., and Neel, B. G. (1993) Anal. Biochem. 210, 179-187[CrossRef][Medline] [Order article via Infotrieve]
10. Beckers, C. J., Dubremetz, J. F., Mercereau-Puijalon, O., and Joiner, K. A. (1994) J. Cell Biol. 127, 947-961[Abstract/Free Full Text]
11. Karsten, V., Qi, H., Beckers, C. J., and Joiner, K. A. (1997) Methods 13, 103-111[CrossRef][Medline] [Order article via Infotrieve]
12. Fichera, M. E., and Roos, D. S. (1997) Nature 390, 407-409[CrossRef][Medline] [Order article via Infotrieve]
13. Deimann, W., Angermüller, S., Stoward, P. J., and Fahimi, H. D. (1991) in Histochemistry (Stoward, P. J. , and Everson Pearse, A. G., eds), Vol. 3 , pp. 573-575, Churchill Livingstone, Edinburgh, UK
14. Altschul, S. F., Madden, T. L., Schäffer, A. A., Zhang, J., Zhang, Z., Miller, W., and Lipman, D. J. (1997) Nucleic Acids Res. 25, 3389-3402[Abstract/Free Full Text]
15. von Ossowski, I., Hausner, G., and Loewen, P. C. (1993) J. Mol. Evol. 37, 71-76[Medline] [Order article via Infotrieve]
16. Gouet, P., Jouve, H.-M., and Dideberg, O. (1995) J. Mol. Biol. 249, 933-954[CrossRef][Medline] [Order article via Infotrieve]
17. Loewen, P. (1996) Gene (Amst.) 197, 39-44
18. Kirkman, H. N., Rolfo, M., Ferraris, A. M., and Gaetani, G. F. (1999) J. Biol. Chem. 274, 13908-13914[Abstract/Free Full Text]
19. Zamocky, M., Herzog, C., Nykyri, L. M., and Koller, F. (1995) FEBS Lett. 367, 241-245[CrossRef][Medline] [Order article via Infotrieve]
20. Swinkels, B. W., Gould, S. J., and Subramani, S. (1992) FEBS Lett. 305, 133-136[CrossRef][Medline] [Order article via Infotrieve]
21. Waller, R. F., Keeling, P. J., Donald, R. G. K., Striepen, B., Handman, E., Lang-Unnasch, N., Cowman, A. F., Gurdyal, S. B., Roos, D. S., and McFadden, I. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 12352-12357[Abstract/Free Full Text]
22. Soldati, D. (1999) Parasitol. Today 15, 5-7[CrossRef][Medline] [Order article via Infotrieve]
23. Thompson, J. D., Higgins, D. G., and Gibson, T. J. (1994) Nucleic Acids Res. 22, 4673-4680[Abstract/Free Full Text]


Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mol Biol EvolHome page
A. Schluter, S. Fourcade, R. Ripp, J. L. Mandel, O. Poch, and A. Pujol
The Evolutionary Origin of Peroxisomes: An ER-Peroxisome Connection
Mol. Biol. Evol., April 1, 2006; 23(4): 838 - 845.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X. W. Zhou, B. F. C. Kafsack, R. N. Cole, P. Beckett, R. F. Shen, and V. B. Carruthers
The Opportunistic Pathogen Toxoplasma gondii Deploys a Diverse Legion of Invasion and Survival Proteins
J. Biol. Chem., October 7, 2005; 280(40): 34233 - 34244.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. E. Akerman and S. Muller
Peroxiredoxin-linked Detoxification of Hydroperoxides in Toxoplasma gondii
J. Biol. Chem., January 7, 2005; 280(1): 564 - 570.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
M Ding, C Clayton, and D Soldati
Toxoplasma gondii catalase: are there peroxisomes in toxoplasma?
J. Cell Sci., January 7, 2000; 113(13): 2409 - 2419.
[Abstract] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kaasch, A. J.
Right arrow Articles by Joiner, K. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kaasch, A. J.
Right arrow Articles by Joiner, K. A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.